BridgeBio Competitors and Similar CompaniesClear all
BridgeBio's competitors and similar companies include R-Pharm and Acceleron Pharma.
 BridgeBio BridgeBio is a company focused on discovering and developing drugs for patients with grievous genetic diseases. | |||
Founding Date | Founding Date 2014 | Founding Date 2001 | Founding Date 2003 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Palo Alto, US HQ | Locations Moskva, RU HQ Baku, AZ Illertissen, DE Lawrence Township, US | Locations Cambridge, US HQ Zug, CH |
Employees | Employees 24863% increase | Employees 462 | Employees 636% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $502.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $92.5m (FY, 2020) |
Net income | Net income ($732.9m) (FY, 2025) | Net income N/A | Net income ($166m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 474.2m | Total funding raised N/A | Total funding raised $ 141.8m |
For sources of this data, please see the company profile
View Company Profiles
Acceleron Pharma
HQ
Cambridge, US
Acceleron Pharma is a clinical-stage biopharmaceutical company.
View company